The Epidemiology of Leukaemia in Zimbabwe: A Ten Year Retrospective Study
Journal Title: Haematology International Journal - Year 2017, Vol 1, Issue 1
Abstract
1.1. Background: Haematological malignancies are defined as primary cancers of blood cells. Leukaemia constitutes more than fifty-five percent of haematological malignancies. The epidemiology of leukaemia in Zimbabwe is currently unknown. 1.2. Aim: To investigate the incidence of leukaemia in Zimbabwe during a ten year period from 2004 to 2013. 1.3. Objective: To understand the latest epidemiology of leukaemia in the country in order to effectively manage the disease and inform policy makers. 1.4. Methods: A ten year cross sectional retrospective epidemiological study was carried out on 601 reported cases of leukaemia registered at the Zimbabwe National Cancer Registry from 1January 2004 to 31 December 2013. 1.5. Results: More males (59%) had leukaemia than female (41%). Children (28%) developed leukaemia more than the adults. Chronic myelogenous leukaemia (29%) was the most common type of leukaemia, followed by acute myeloid leukaemia (24%), acute lymphoblastic leukaemia (18%), unclassified (17%) and chronic lymphocytic leukaemia (12%). Harare had the highest and Matebeleland South the lowest reported cases of leukaemia. Unemployed adults had the highest incidence followed by children. 1.6. Conclusion: Zimbabwe has an increasing burden of the leukaemia compared to developed countries. A high proportion of leukaemia was not classified, making it difficult to come up with reliable subtypes of the disease. More men and children were affected than women and the elderly respectively. The distribution of types of leukaemia was consistent with literature information. Unemployed people appeared to have a higher risk for developing leukaemia in Zimbabwe.
Authors and Affiliations
Arthur Mandisodza
Keywords
Related Articles
- EP ID EP291032
- DOI -
- Views 101
- Downloads 0
Management of Adult Onset Familial Hemophagocytic Lymphohistiocytosis (FHL): A Dilemma
Background: Perforin gene (PRF1) mutations cause the familial form of hemophagocytic lymphohistiocytosis (HLH). Case presentation: Here, we report a 36-year-old male with familial HLH, who was initially thought to be se...
Hemochromatosis Gene Mutation and Erythrocytosis
In a patient group presenting with either increased Hgb level or high RBC count HFE gene mutations occured in two-third of the patients. The explanation for this phenomenon is still missing. These patients had normal ery...
Iatrogenic Cushing’s Syndrome with Secondary Adrenal Suppression Misdiagnosed as Protease Inhibitor-Induced Lipodystrophy in an HIV Positive Patient: Case Report
1.1. Background: Ritonavir is a commonly prescribed protease inhibitor (PI) which is used in low doses to boost levels of other protease inhibitors pharmacokinetically. It is a potent inhibitor of hepatic cytochrome P450...
Cladribine an Alternative for Midostaurine in FLT3 Positive Acute Myeloid Leukemia
Midostaurinis registered for the indication newly diagnosed acute myeloid leukemia that is FLT3 mutation positive in combination with standard cytarabine and daunorubicine induction and cytarabine consolidation. The regi...
Long-lasting Responses to Immunomodulatory Drugs (IMIDs) in Combination with Dexamethasone in Multiple Myeloma; Identification of Exceptional Responders at any Treatment Line
1.1. Background: There is a growing interest in the study of patients that achieve exceptionally long-lasting remissions although suffering from incurable neoplastic disorders. This is the case for multiple myeloma (MM),...